The Discure System is designed to treat and reverse degenerative disc disease (DDD), reduce pain, and improve function and quality of life in patients, via a minimally invasive, implantable bioelectronic approach. Unlike existing treatments, that are symptom-focused, the Discure System is a disease-modifying solution, aiming to reduce the use of opioids and the need for invasive back surgery.
Discure was granted Breakthrough Device Designation by the FDA; has received multiple awards, including for “Best New Technology in Spine Care” at the North American Spine Society (NASS) annual meeting; and holds partnerships with multiple top-tier providers in the US as well as a Fortune 50 healthcare company.
